Context: New treatment for menopausal transition. Objective: To assess the efficacy of a combined nutraceutical supplementation on the perimenopausal symptoms and early metabolic alterations. Methods: It is a prospective observational study. The study took place at the Department of Obstetrics and Gynecology service for menopause disorders. Patients: Sixty-four women in menopausal transition, who attended our service having menopausal symptoms. Interventions: Thirty-two women enrolled in the study group were prescribed one daily combined nutraceutical tablet for 6 months. Thirty-two aged matched women consisted the control group. Main outcome measures: Perimenopausal symptoms’ intensity was assessed by the modified Kuppermann index at enrollment and at 3 and 6 months of treatment. At the baseline and at the end of the study, patients underwent a clinical evaluation, a pelvic ultrasound and blood samples analysis. Results: In the nutraceutical supplemented group, a significant reduction in menopausal symptoms is demonstrated by Kuppermann index, after 3 and 6-months of supplementation (p<0.01 and p<0.001 respectively). In comparison with basal values, a significant improvement was shown in particular for hot flashes (p<0.001), insomnia (p<0.01) fatigue (p<0.01) and irritability (p<0.01.) Metabolic parameters did not show a significant change in the nutraceutical supplemented group. In control group, total Cholesterol level showed a significant increase (p<0.05). Conclusion: Combined nutraceutical supplementation provides an effective and safe solution for early symptoms occurring during menopausal transition.